Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value-Reference-Cited by-同舟云学术

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Published:2012-10-08 Issue:23 Volume:18 Page:6531-6541
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Gavin Patrick G.,Colangelo Linda H.,Fumagalli Debora,Tanaka Noriko,Remillard Matthew Y.,Yothers Greg,Kim Chungyeul,Taniyama Yusuke,Kim Seung Il,Choi Hyun Joo,Blackmon Nicole L.,Lipchik Corey,Petrelli Nicholas J.,O'Connell Michael J.,Wolmark Norman,Paik Soonmyung,Pogue-Geile Kay L.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes of stage II and III colorectal cancers treated by postoperative adjuvant chemotherapy based on the mismatch repair status;Surgery Today;2024-09-09

2. Serum Uric Acid Level May Be a Predictive Factor for BRAF V600E Mutation in Older Patients with Metastatic Colorectal Cancer: An Exploratory Analysis;Oncology;2024-07-17

3. State of the art: Targeting microsatellite instability in gastrointestinal cancers;Critical Reviews in Oncology/Hematology;2024-07

4. Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review;Diagnostics;2024-05-12

5. Microsatellite instability evaluation by a novel PCR‐based 8‐loci test kit in colorectal cancer;Biotechnology and Applied Biochemistry;2024-03-31